We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+3.9%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$126M
AUM Growth
-$27.3M
Cap. Flow
-$37.9M
Cap. Flow %
-30.16%
Top 10 Hldgs %
76.77%
Holding
47
New
7
Increased
5
Reduced
7
Closed
9

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$7.21M
2
AKRX
Akorn Inc
AKRX
+$4.67M
3
ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
+$3.4M
4
BMY icon
Bristol-Myers Squibb
BMY
+$2.12M
5
UNH icon
UnitedHealth
UNH
+$2M

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$13.8M
2
AGN
Allergan plc
AGN
+$11.8M
3
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$9.78M
4
CXRX
Concordia International Corp. Common Stock
CXRX
+$6.28M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$4.52M

Sector Composition

Rank Sector Weight
1 Healthcare 53.99%
2 Consumer Discretionary 13.89%
3 Communication Services 8.45%
4 Financials 5.94%
5 Technology 1.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STRR
26
DELISTED
Star Equity Holdings
STRR
$568K 0.45%
2,205
– –
ATRS
27
DELISTED
Antares Pharma, Inc.
ATRS
$500K 0.4%
475,897
+333,699
+235% +$322K
ADMS
28
DELISTED
Adamas Pharmaceuticals
ADMS
$456K 0.36%
30,140
– –
XNPT
29
DELISTED
XENOPORT, INC.
XNPT
$352K 0.28%
50,000
– –
TLGT
30
DELISTED
Teligent, Inc
TLGT
$314K 0.25%
4,392
-1,990
-31% -$116K
PJT icon
31
PJT Partners
PJT
$4.37B
$230K 0.18%
10,000
+5,000
+100% +$120K
FOLD
32
DELISTED
Amicus Therapeutics
FOLD
$109K 0.09%
20,000
– –
CCLD icon
33
CareCloud
CCLD
$94.3M
$56K 0.04%
63,771
– –
CPIX icon
34
Cumberland Pharmaceuticals
CPIX
$99M
$49K 0.04%
10,939
– –
VANI icon
35
Vivani Medical
VANI
$110M
$30K 0.02%
354
– –
CTIC
36
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$17K 0.01%
5,025
– –
VXRT
37
DELISTED
Vaxart
VXRT
$12K 0.01%
783
– –
NSPH
38
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$6K ﹤0.01%
3,451
– –
CMG icon
39
Chipotle Mexican Grill
CMG
$40.8B
– –
-100,000
Closed -$942K
GOOG icon
40
Alphabet (Google) Class C
GOOG
$3.9T
– –
-121,280
Closed -$4.52M
NFLX icon
41
Netflix
NFLX
$292B
– –
-174,840
Closed -$1.79M
SBUX icon
42
Starbucks
SBUX
$118B
– –
-230,690
Closed -$13.8M
SRPT icon
43
Sarepta Therapeutics
SRPT
$1.66B
– –
-17,974
Closed -$351K
ALXN
44
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-25,424
Closed -$3.54M
AGN
45
DELISTED
Allergan plc
AGN
– –
-44,189
Closed -$11.8M
CXRX
46
DELISTED
Concordia International Corp. Common Stock
CXRX
– –
-245,400
Closed -$6.28M
IPXL
47
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-53,373
Closed -$1.71M
1
2

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
BB
Burford Brothers Dallas, Texas $244M AUM 24.94% 1-Year Est. Return
QHA
Quarry Hill Advisors St Paul, Minnesota $243M AUM 24.02% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return

JW Asset Management's Q2 2016 Portfolio in Review

As of Q2 2016, JW Asset Management held 47 positions worth $126M, down 18% from $153M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

JW Asset Management withdrew a net $37.9M in Q2 2016, closing 9 positions and reducing 7 holdings. Its most notable exit was Starbucks, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 61% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, JW Asset Management opened a new position in Bristol-Myers Squibb worth $2.21M.

  • JW Asset Management's largest Q2 2016 buy was Bristol-Myers Squibb: 30,000 shares worth $2.21M.
  • JW Asset Management added most to Amazon in Q2 2016, an estimated $7.21M increase.
  • JW Asset Management's biggest Q2 2016 reduction was Eagle Pharmaceuticals, Inc., cutting an estimated $9.78M.
  • JW Asset Management fully exited Starbucks in Q2 2016, selling an estimated $13.8M.
  • JW Asset Management's ten largest holdings make up 77% of its $126M portfolio in Q2 2016.
  • JW Asset Management opened 7 new positions and closed 9 in Q2 2016.
  • JW Asset Management's portfolio value fell 18% quarter-over-quarter to $126M.

Based on JW Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.